Clinical Trial

Relıabılıty and valıdıty of the Two-minute Test wıth Multiple Sclerosis

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The study will include 50 MS patients who were examined by a specialist neurologist diagnosed according to McDonalds criteria in the Neurology Outpatient Clinic of SANKO University Sani Konukoğlu Application and Research Hospital and whose informed consent was obtained. Ethical approval of the study was obtained from SANKO University Non-Interventional Clinical Research Ethics Committee (No:2025/01- ethics committee decision No:2). MS patients between the ages of 18-65 years, with an Expanded Disability Status Scale (EDSS) score ≤ 4, who are not pregnant, who have not had an attack in the last 1 month and who have not received corticosteroid treatment will be included in the study. Individuals who have taken any medication that may affect walking and balance ability in the last month, have orthopedic, other neurologic diseases and cognitive problems will not be included in the study. Demographic information (age, height, weight, body mass index and gender) of individuals with MS will be recorded. Firstly, the tests will be explained to the individuals in detail.Assessments will be performed by a physiotherapist with 10 years of experience in this field.
Trial Details
NCT Number NCT06849960
Lead Sponsor Sanko University
Conditions Multiple Sclerosis
Enrollment 50 participants
Start Date 2025-02-01
Primary Completion 2025-02-15 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-27